Detalles de la búsqueda
1.
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Brief Bioinform
; 24(2)2023 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653909
2.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Breast Cancer Res
; 23(1): 38, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761970
3.
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study.
Br J Cancer
; 125(1): 94-100, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33953347
4.
Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
Epidemiol Prev
; 45(1-2): 28-36, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884840
5.
Using CTCs for pharmacogenomic analysis.
Pharmacol Res
; 106: 92-100, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26921662
6.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
JCO Precis Oncol
; 8: e2300285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427931
7.
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
Future Oncol
; 9(10): 1477-87, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24106899
8.
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
Cancers (Basel)
; 13(11)2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34072070
9.
The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology.
Expert Rev Pharmacoecon Outcomes Res
; 21(3): 503-509, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32403958
10.
A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
Clin Breast Cancer
; 21(4): e332-e339, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33353853
11.
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Biomolecules
; 10(12)2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33334040
12.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 689, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32736597
13.
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial.
Clin Cancer Res
; 26(9): 2131-2139, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31937617
14.
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.
Breast Cancer Res
; 11(2): 205, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19435470
15.
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
Breast Cancer Res Treat
; 118(3): 523-30, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19597704
16.
Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice.
Front Oncol
; 9: 666, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31396487
17.
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).
Eur J Cancer
; 114: 55-66, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31059974
18.
Arsenate tolerance in Silene paradoxa does not rely on phytochelatin-dependent sequestration.
Environ Pollut
; 152(3): 585-91, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17707110
19.
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.
Oncotarget
; 9(23): 16389-16399, 2018 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29662653
20.
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
Oncotarget
; 7(18): 26107-19, 2016 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034166